Literature DB >> 1461370

Muscarinic receptor subtypes in bovine adrenal medulla.

J S Aguilar1, J J Ballesta, J A Reig, M Palmero, S Viniegra, M Criado.   

Abstract

Catecholamine secretion in the bovine adrenal medulla is evoked largely by nicotinic receptor activation. However, bovine adrenal medulla also contain muscarinic receptors that mediate several cell responses. To understand the physiological role of muscarinic receptors in the bovine adrenal medulla it is important to identify the pharmacological subtypes present in this tissue. For this, we analyzed the abilities of different selective muscarinic antagonists in displacing the binding of the non-selective antagonist [3H] quinuclidinyl benzylate to an enriched plasma membrane fraction prepared from bovine adrenal medulla. All the selective antagonists bind at least two bindings sites with different affinities. The binding profile of the sites with high proportion is similar to the M2 subtype and those present in low proportion have a M1 profile. However, some variation in the proportion of the sites for the different ligands suggest the presence of the third pharmacological subtype (M3). We conclude that the sites in high proportion (60-80%) correspond to M2 muscarinic subtypes, and the rest is constituted by M1 plus M3 subtypes. The presence of multiplicity of subtypes in the adrenal medulla membranes suggests a diversity of functions of muscarinic receptors in the adrenal gland.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1461370     DOI: 10.1007/bf00968406

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  26 in total

1.  Rapid rise in cyclic GMP accompanies catecholamine secretion in suspensions of isolated adrenal chromaffin cells.

Authors:  A S Schneider; H T Cline; S Lemaire
Journal:  Life Sci       Date:  1979-04-09       Impact factor: 5.037

2.  Muscarinic receptor-mediated increase in cyclic GMP level in isolated bovine adrenal medullary cells.

Authors:  N Yanagihara; M Isosaki; T Ohuchi; M Oka
Journal:  FEBS Lett       Date:  1979-09-15       Impact factor: 4.124

3.  Studies of chick adrenal medulla in organ culture.

Authors:  F H Ledbetter; N Kirshner
Journal:  Biochem Pharmacol       Date:  1975-05-01       Impact factor: 5.858

4.  Molecular neurobiology. Separating receptor subtypes from their shadows.

Authors:  E A Barnard
Journal:  Nature       Date:  1988-09-22       Impact factor: 49.962

Review 5.  The molecular basis of muscarinic receptor diversity.

Authors:  T I Bonner
Journal:  Trends Neurosci       Date:  1989-04       Impact factor: 13.837

6.  Effect of activation of muscarinic receptors on intracellular free calcium and secretion in bovine adrenal chromaffin cells.

Authors:  T R Cheek; R D Burgoyne
Journal:  Biochim Biophys Acta       Date:  1985-07-30

7.  Cholinergic muscarinic receptors of bovine adrenal medulla.

Authors:  S O Kayaalp; N H Neff
Journal:  Neuropharmacology       Date:  1979-11       Impact factor: 5.250

8.  Possible muscarinic regulation of catecholamine secretion mediated by cyclic GMP in isolated bovine adrenal chromaffin cells.

Authors:  G Derome; R Tseng; P Mercier; I Lemaire; S Lemaire
Journal:  Biochem Pharmacol       Date:  1981-04-15       Impact factor: 5.858

9.  Secretory and radioligand binding studies on muscarinic receptors in bovine and feline chromaffin cells.

Authors:  J J Ballesta; R Borges; A G García; M J Hidalgo
Journal:  J Physiol       Date:  1989-11       Impact factor: 5.182

10.  Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors.

Authors:  E G Peralta; A Ashkenazi; J W Winslow; D H Smith; J Ramachandran; D J Capon
Journal:  EMBO J       Date:  1987-12-20       Impact factor: 11.598

View more
  1 in total

1.  Cholinoceptor-mediated control of catecholamine release from chromaffin cells in the American eel, Anguilla rostrata.

Authors:  S G Reid; S F Perry
Journal:  J Comp Physiol B       Date:  1995       Impact factor: 2.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.